statistiche ricercatore

GHIDINI, MICHELE

Distribuzione geografica

Continente	#
NA - Nord America	2.933
AS - Asia	1.667
EU - Europa	1.050
Continente sconosciuto - Info sul continente non disponibili	228
SA - Sud America	112
AF - Africa	41
Totale	6.031

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.801
SG - Singapore	695
IT - Italia	639
CN - Cina	433
VN - Vietnam	164
FR - Francia	150
HK - Hong Kong	144
BD - Bangladesh	102
BR - Brasile	72
CA - Canada	55
DE - Germania	54
GB - Regno Unito	49
IE - Irlanda	41
SE - Svezia	37
IN - India	31
RU - Federazione Russa	26
MX - Messico	24
NG - Nigeria	20
JP - Giappone	17
FI - Finlandia	13
NL - Olanda	13
AR - Argentina	12
CR - Costa Rica	11
IQ - Iraq	11
TH - Thailandia	10
TT - Trinidad e Tobago	8
ES - Italia	7
JO - Giordania	7
NI - Nicaragua	7
TR - Turchia	7
CO - Colombia	6
EC - Ecuador	6
HN - Honduras	6
ID - Indonesia	6
PL - Polonia	6
VE - Venezuela	6
JM - Giamaica	5
KH - Cambogia	5
PK - Pakistan	5
ZA - Sudafrica	5
BB - Barbados	4
GT - Guatemala	4
KE - Kenya	4
LT - Lituania	4
MY - Malesia	4
PE - Perù	4
PH - Filippine	4
SA - Arabia Saudita	4
AT - Austria	3
PR - Porto Rico	3
RS - Serbia	3
TN - Tunisia	3
AE - Emirati Arabi Uniti	2
CL - Cile	2
DZ - Algeria	2
EG - Egitto	2
IL - Israele	2
LB - Libano	2
MA - Marocco	2
NP - Nepal	2
OM - Oman	2
SV - El Salvador	2
SY - Repubblica araba siriana	2
UY - Uruguay	2
AG - Antigua e Barbuda	1
AZ - Azerbaigian	1
BH - Bahrain	1
BO - Bolivia	1
BZ - Belize	1
CG - Congo	1
GR - Grecia	1
HT - Haiti	1
KR - Corea	1
KW - Kuwait	1
LV - Lettonia	1
MD - Moldavia	1
ML - Mali	1
PT - Portogallo	1
PY - Paraguay	1
SC - Seychelles	1
TW - Taiwan	1
UA - Ucraina	1
UZ - Uzbekistan	1
Totale	5.803

Salva come PNG Salva come JPEG

Città	#
San Jose	628
Council Bluffs	586
Singapore	414
Milan	333
Ashburn	216
Hong Kong	140
Lauterbourg	138
Beijing	121
Santa Clara	90
Rome	77
Chicago	71
New York	65
Dallas	63
Los Angeles	61
Hanoi	52
Ho Chi Minh City	43
Dublin	42
Boardman	39
Bar Harbor	38
Princeton	37
The Dalles	33
Nyköping	27
Orem	25
Abuja	20
Frankfurt am Main	20
London	17
Naples	17
Brooklyn	15
San Diego	15
Atlanta	14
Denver	14
Houston	14
Mexico City	14
Schiffdorf	14
Tampa	14
Montreal	13
Salt Lake City	13
Guangzhou	12
Phoenix	12
Chennai	10
São Paulo	10
Turin	10
Fairfield	9
Helsinki	9
Seattle	9
Shanghai	9
Bangkok	8
San José	8
Tianjin	8
Amman	7
Chandler	7
Da Nang	7
Managua	7
Mumbai	7
Nuremberg	7
Poplar	7
San Francisco	7
Boston	6
Buffalo	6
Cleveland	6
Elk Grove Village	6
Hangzhou	6
Jacksonville	6
Las Vegas	6
Newark	6
Stockholm	6
Tokyo	6
Toronto	6
Warsaw	6
Baghdad	5
Charleston	5
Chengdu	5
Detroit	5
Genoa	5
Hải Dương	5
Miami	5
Ogden	5
Paris	5
Phnom Penh	5
Queens	5
The Bronx	5
Varese	5
Bologna	4
Bridgetown	4
Calgary	4
Cambridge	4
Charlotte	4
Fayetteville	4
Figino	4
Haiphong	4
Kingston	4
Manchester	4
Philadelphia	4
Piscataway	4
Pittsburgh	4
Pune	4
Shenzhen	4
Sterling	4
Trapani	4
Verona	4
Totale	3.932

Salva come PNG Salva come JPEG

Nome	#
Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis	134
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation	118
A review of clinical practice guidelines and treatment recommendations for cancer care in the COVID-19 pandemic	118
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes	97
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study	81
Impact of bmi on survival outcomes of immunotherapy in solid tumors: A systematic review	81
IDH signalling pathway in cholangiocarcinoma: From biological rationale to therapeutic targeting	80
Triage process for the assessment of coronavirus disease 2019-positive patients with cancer: The ONCOVID prospective study	80
Association of steroids use with survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis	77
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer	75
Targeting kras in solid tumors: Current challenges and future opportunities of novel kras inhibitors	75
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?	74
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study	74
Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres	73
Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma	73
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic	73
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort	70
Strategies for increasing the effectiveness of aromatase inhibitors in locally advanced breast cancer: An evidence-based review on current options	69
Metabolic disorders and the risk of cholangiocarcinoma	69
Impact of use of gastric-acid suppressants and oral anti-cancer agents on survival outcomes: A systematic review and meta-analysis	69
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?	65
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial	65
Letter of response to comments on: Developing a risk assessment score for patients with cancer during COVID-19 pandemic: A war on two fronts	65
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status	64
Nivolumab plus ipilimumab for the first-line treatment of metastatic NSCLC	64
Association of Obesity With Survival Outcomes in Patients With Cancer A Systematic Review and Meta-analysis	62
Coronavirus infection and immune system: An insight of COVID-19 in cancer patients	62
The appropriateness of invasive ventilation in covid-19 positive cancer patients: Proposal of a new prognostic score	61
Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancer	57
Clinical Evidence for Microbiome-Based Strategies in Cancer Immunotherapy: A State-of-the-Art Review	47
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer A Systematic Review and Pooled Analysis	47
Molecular profiling of tissue and circulating cancer-related ncRNA in hepatocellular carcinoma	46
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis	46
Harrison. Principi di medicina interna.	43
Viral hepatitis and immunotherapy outcome in advanced hepatocellular carcinoma: A comprehensive umbrella review of 15 meta-analyses	40
Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis	39
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey	38
Nanomedicine for the Delivery of RNA in Cancer	37
Molecular profiling of tissue- and circulating cancer related non coding RNAs in hepatocellular carcinoma	37
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches	36
Effect of aspirin use on cancer incidence and mortality: An updated systematic review and meta-analysis	35
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer	35
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis	35
Better survival of patients with oligo- compared with polymetastatic cancers: A systematic review and meta-analysis of 173 studies	34
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)	34
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic	34
Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High Cancers A Systematic Review and Meta-analysis	32
Correlation between Olive Oil Intake and Gut Microbiota in Colorectal Cancer Prevention	31
Real-world guideline application in the management of pancreatic cancer patients: the Italian GARIBALDI study	31
Biliary tract cancer: current challenges and future prospects	31
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario	30
Body weight loss (BWL) as a prognostic/predictive factor in previously treated patients (pts) with metastatic gastric or gastroesophageal junction cancer (mGC/GEJC): Post-hoc analyses of the phase III tags trial	30
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry	30
Clinical impact of neutropenia and febrile neutropenia in mCRC pts treated with FOLFOXIRI/bevacizumab (bev): A pooled analysis of TRIBE and TRIBE2 studies	30
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer	30
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study	30
Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis	29
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies	29
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study	29
Treatment options for advanced small bowel adenocarcinoma: a systematic review	29
Expression of exosomal let-7g in biofluids and outcome in colon cancer patient treated with anti-EGFR therapy	28
Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis	28
Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer	28
Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis	27
Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC)	27
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer	27
Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study	26
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?	26
Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective	25
Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies	25
Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicity	25
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study	25
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients	25
Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies	25
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer A Systematic Review and Meta-analysis	25
Incidence of influenza-like illness (ILI) in cancer patients during COVID-19: The ONCOVID prospective observational study	25
MicroRNA deregulation of the serine synthesis pathway controls intrinsic and non-cell autonomous mechanism of resistance to Regorafenib in metastatic colorectal cancer (mCRC)	25
Advances in the pharmacological management of neutropenia in solid tumors: the advent of biosimilars	25
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST	24
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy	24
Observational prospective study of Italian guidelines application for patients with pancreatic ductal adenocarcinoma	24
Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis	24
Comparative Efficacy of 21 Treatment Strategies for Resectable Pancreatic Cancer: A Network Meta-Analysis	24
Clinical development of mTor inhibitors for renal cancer	24
The impact of prior therapies on outcomes with trifluridine/tipiracil (FTD/TPI) in the phase III TAGS trial	24
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis	24
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+Cells	24
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry	24
Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies	24
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial	23
Renal Function Assessment Gap in Clinical Practice: An Awkward Truth	23
MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside	23
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim	23
Weekly epirubicin as salvage therapy inpatient with gemcitabine-refractory pancreatic cancer	23
Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data	23
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?	23
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities	23
Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy	23
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy Subgroup Analyses of a Randomized Clinical Trial	23
Predictors of Lymph Node Metastasis in T1 Colorectal Cancer in Young Patients: Results from a National Cancer Registry	23
Totale	4.293

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	37.065
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	37.065

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	81	0	0	0	0	3	0	35	4	3	2	13	21
2022/2023	115	18	4	8	2	7	29	0	10	12	17	1	7
2023/2024	423	44	77	70	89	112	4	3	3	17	4	0	0
2024/2025	299	5	4	51	4	2	23	4	4	45	33	23	101
2025/2026	4.065	40	62	44	110	411	270	912	306	669	488	423	330
2026/2027	1.048	399	433	216	0	0	0	0	0	0	0	0	0
Totale													6.031